NIAID | Technology Transfer

Anti-Coronavirus Antibodies And Methods Of Use

Read more about Anti-Coronavirus Antibodies And Methods Of Use

South Africa
2022/10038
Filed on 2021-03-04

Anti-Coronavirus Antibodies And Methods Of Use

Read more about Anti-Coronavirus Antibodies And Methods Of Use

Mexico
MX/a/2022/011142
Filed on 2020-12-09

Anti-Coronavirus Antibodies And Methods Of Use

Read more about Anti-Coronavirus Antibodies And Methods Of Use

South Korea
10-2022-7032747
Filed on 2021-03-04

PREFUSION PIV F IMMUNOGENS AND THEIR USE

Read more about PREFUSION PIV F IMMUNOGENS AND THEIR USE

Ireland
17835951.9
Filed on 2017-10-25

PREFUSION PIV F IMMUNOGENS AND THEIR USE

Read more about PREFUSION PIV F IMMUNOGENS AND THEIR USE

United Kingdom
17835951.9
Filed on 2017-10-25

PREFUSION PIV F IMMUNOGENS AND THEIR USE

Read more about PREFUSION PIV F IMMUNOGENS AND THEIR USE

France
17835951.9
Filed on 2017-10-25

PREFUSION PIV F IMMUNOGENS AND THEIR USE

Read more about PREFUSION PIV F IMMUNOGENS AND THEIR USE

Germany
17835951.9
Filed on 2017-10-25

PREFUSION PIV F IMMUNOGENS AND THEIR USE

Read more about PREFUSION PIV F IMMUNOGENS AND THEIR USE

Switzerland
17835951.9
Filed on 2017-10-25

PREFUSION PIV F IMMUNOGENS AND THEIR USE

Read more about PREFUSION PIV F IMMUNOGENS AND THEIR USE

Belgium
17835951.9
Filed on 2017-10-25

VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES

Read more about VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES

Australia
2022256195
Filed on 2022-10-21

Subscribe to NIAID